Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms

[1]  D. Tamborero,et al.  Mass spectrometry-based proteomic analysis of NSCLC tumor and biopsy samples , 2021 .

[2]  D. Tamborero,et al.  STK11 pathway in vitro validation , 2021 .

[3]  D. Tamborero,et al.  Immune landscape evaluation of NSCLC clinical samples , 2021 .

[4]  Husen M. Umer,et al.  Bioinformatics analysis of NSCLC multi-omics data , 2021 .

[5]  P. Van Loo,et al.  Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition , 2021, Cell.

[6]  J. Vallon-Christersson,et al.  Methylation Patterns and Chromatin Accessibility in Neuroendocrine Lung Cancer , 2020, Cancers.

[7]  I. Jonassen,et al.  Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression , 2020, Cell.

[8]  Junming Xu,et al.  Integrative Proteomic Characterization of Human Lung Adenocarcinoma , 2020, Cell.

[9]  S. Anders,et al.  DEqMS: A Method for Accurate Variance Estimation in Differential Protein Expression Analysis* , 2020, Molecular & Cellular Proteomics.

[10]  Peter B. McGarvey,et al.  Proteogenomic Characterization of Endometrial Carcinoma , 2020, Cell.

[11]  Sara R. Savage,et al.  Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma , 2020, Cell.

[12]  D. Schadendorf,et al.  Tertiary lymphoid structures improve immunotherapy and survival in melanoma , 2020, Nature.

[13]  Irving L. Weissman,et al.  A molecular cell atlas of the human lung from single cell RNA sequencing , 2019, Nature.

[14]  Kongming Wu,et al.  Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4 , 2019, Molecular Cancer.

[15]  D. Vignali,et al.  Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups , 2019, Nature Immunology.

[16]  Brian J. Stevenson,et al.  Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes , 2019, Nature Communications.

[17]  Sara R. Selitsky,et al.  Alternative tumour-specific antigens , 2019, Nature Reviews Cancer.

[18]  Audrey Y. Chu,et al.  An integrative cross-omics analysis of DNA methylation sites of glucose and insulin homeostasis , 2019, Nature Communications.

[19]  C. Sautès-Fridman,et al.  Tertiary lymphoid structures in the era of cancer immunotherapy , 2019, Nature Reviews Cancer.

[20]  G. Mills,et al.  Breast cancer quantitative proteome and proteogenomic landscape , 2019, Nature Communications.

[21]  M. Skopkova,et al.  Novel insights into genetics and clinics of the HNF1A-MODY , 2019, Endocrine regulations.

[22]  K. Kerr,et al.  Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC , 2019, Nature Reviews Clinical Oncology.

[23]  G. Zhu,et al.  Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3 , 2019, Cell.

[24]  Andreas Ruepp,et al.  CORUM: the comprehensive resource of mammalian protein complexes—2019 , 2018, Nucleic Acids Res..

[25]  Katherine M Fellows,et al.  Proteogenomic landscape of squamous cell lung cancer , 2019, Nature Communications.

[26]  P. Gendron,et al.  Noncoding regions are the main source of targetable tumor-specific antigens , 2018, Science Translational Medicine.

[27]  K. Grønbæk,et al.  Human endogenous retroviruses and their implication for immunotherapeutics of cancer. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  Chwee Teck Lim,et al.  Descriptor : A merged lung cancer transcriptome dataset for clinical predictive modeling , 2018 .

[29]  I. Wistuba,et al.  Immunohistochemical and Image Analysis‐Based Study Shows That Several Immune Checkpoints are Co‐expressed in Non–Small Cell Lung Carcinoma Tumors , 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[30]  A. Jolma,et al.  A protein activity assay to measure global transcription factor activity reveals determinants of chromatin accessibility , 2018, Nature Biotechnology.

[31]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[32]  M. Huss,et al.  Discovery of coding regions in the human genome by integrated proteogenomics analysis workflow , 2018, Nature Communications.

[33]  Xia Yang,et al.  The Kinase mTORC1 Promotes the Generation and Suppressive Function of Follicular Regulatory T Cells. , 2017, Immunity.

[34]  Johan Staaf,et al.  Gene Expression Profiling of Large Cell Lung Cancer Links Transcriptional Phenotypes to the New Histological WHO 2015 Classification , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[35]  Charles H. Yoon,et al.  An immunogenic personal neoantigen vaccine for patients with melanoma , 2017, Nature.

[36]  Benjamin P. C. Chen,et al.  CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells , 2017, Nature.

[37]  Pornpimol Charoentong,et al.  Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade , 2016, bioRxiv.

[38]  J. Hilkens,et al.  IRS4 induces mammary tumorigenesis and confers resistance to HER2-targeted therapy through constitutive PI3K/AKT-pathway hyperactivation , 2016, Nature Communications.

[39]  S Kumar,et al.  Hypoxia-induced oxidative stress promotes MUC4 degradation via autophagy to enhance pancreatic cancer cells survival , 2016, Oncogene.

[40]  A. Børresen-Dale,et al.  TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients , 2016, Front. Genet..

[41]  J. Mesirov,et al.  The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .

[42]  Yu Xue,et al.  AnimalTFDB 2.0: a resource for expression, prediction and functional study of animal transcription factors , 2014, Nucleic Acids Res..

[43]  J. Mesirov,et al.  The Molecular Signatures Database (MSigDB) hallmark gene set collection. , 2015, Cell systems.

[44]  S. Almo,et al.  Structure and cancer immunotherapy of the B7 family member B7x. , 2014, Cell reports.

[45]  Johan Staaf,et al.  Genome-wide DNA Methylation Analysis of Lung Carcinoma Reveals One Neuroendocrine and Four Adenocarcinoma Epitypes Associated with Patient Outcome , 2014, Clinical Cancer Research.

[46]  Steven J. M. Jones,et al.  Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.

[47]  H. Uppal,et al.  Direct Reprogramming of Human Fibroblasts to Hepatocyte-Like Cells by Synthetic Modified mRNAs , 2014, PloS one.

[48]  Ying Zhang,et al.  Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. , 2014, Cell stem cell.

[49]  M. Huss,et al.  HiRIEF LC-MS enables deep proteome coverage and unbiased proteogenomics , 2013, Nature Methods.

[50]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[51]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[52]  D. Tollervey,et al.  Mapping the Human miRNA Interactome by CLASH Reveals Frequent Noncanonical Binding , 2013, Cell.

[53]  Sridhar Ramaswamy,et al.  Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..

[54]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[55]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.

[56]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[57]  Peter Vogel,et al.  Microenvironment and Immunology Immune Inhibitory Molecules Lag-3 and Pd-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape , 2022 .

[58]  P. Loke,et al.  Tissue-specific expression of B7x protects from CD4 T cell–mediated autoimmunity , 2011, The Journal of experimental medicine.

[59]  M. Selbach,et al.  Global quantification of mammalian gene expression control , 2011, Nature.

[60]  Z. Werb,et al.  Tumors as organs: complex tissues that interface with the entire organism. , 2010, Developmental cell.

[61]  Matthew D. Wilkerson,et al.  ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking , 2010, Bioinform..

[62]  Renaud Gaujoux,et al.  A flexible R package for nonnegative matrix factorization , 2010, BMC Bioinformatics.

[63]  Maria Deak,et al.  Structure of the LKB1-STRAD-MO25 Complex Reveals an Allosteric Mechanism of Kinase Activation , 2009, Science.

[64]  G. Zhu,et al.  Potential Role of Decoy B7-H4 in the Pathogenesis of Rheumatoid Arthritis: A Mouse Model Informed by Clinical Data , 2009, PLoS medicine.

[65]  R. Shaw,et al.  The LKB1–AMPK pathway: metabolism and growth control in tumour suppression , 2009, Nature Reviews Cancer.

[66]  Andrew J. G. Simpson,et al.  CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens , 2008, Nucleic Acids Res..

[67]  Jean-Loup Guillaume,et al.  Fast unfolding of communities in large networks , 2008, 0803.0476.

[68]  David P. Bartel,et al.  Supporting Online Material Materials and Methods Fig. S1 Tables S1 and S2 References Database S1 Disrupting the Pairing between Let-7 and Hmga2 Enhances Oncogenic Transformation , 2022 .

[69]  E. Diamandis,et al.  B7-h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer. , 2006, Cancer research.

[70]  Lloyd J. Old,et al.  Cancer/testis antigens, gametogenesis and cancer , 2005, Nature Reviews Cancer.

[71]  G. Zhu,et al.  B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. , 2003, Immunity.

[72]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[73]  E. Flemington,et al.  Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[74]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[75]  G. Crabtree,et al.  Interaction of a liver-specific nuclear factor with the fibrinogen and alpha 1-antitrypsin promoters. , 1987, Science.